Pacira BioSciences, Inc.

27.04 USD
+0.02 (+0.07%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Pacira BioSciences, Inc. stock is down -4.32% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 69.23% of the previous 12 November’s closed higher than October. In the last 2 Unusual Options Trades, there were 2 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
03 Oct 15:27 20 Oct, 2023 30.00 CALL 1000 0
16 Oct 18:57 21 Jun, 2024 25.00 CALL 40 0

About Pacira BioSciences, Inc.

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectionable suspension. iovera system produces controlled doses of cold temperature only to targeted nerves.

  • HC Wainwright & Co.
    Mon Nov 6, 06:31
  • Piper Sandler
    Fri Nov 3, 17:11
  • RBC Capital
    Fri Nov 3, 15:14
  • Needham
    Fri Nov 3, 06:40